Lexicon Pharmaceuticals, Inc. LXRX
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases, particularly in cardiometabolic and neurological areas. It offers Sotagliflozin, marketed as Inpefa and Zynquista, an oral dual SGLT1/…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees81
TickerLXRX
Statistics
Market Cap$856.0M
Revenue (TTM)$49.8M
Net Income-$50.3M
Net Margin-101.1%
EPS$-0.14
P/E-13.57
P/S12.05
P/B3.95
EV/EBITDA-30.50
ROE-16.0%
Dividend Yield—
Price$2.02
Data: Twelve Data · Revenue = mcap / P/S